Education
About Us
Working with TipRanks
Follow Us
Scandion Oncology A/S (SE:SCOL)
:SCOL
SCOL Stock Chart & Stats
$0.01
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SCOL FAQ
What was Scandion Oncology A/S’s price range in the past 12 months?
Currently, no data Available
What is Scandion Oncology A/S’s market cap?
Currently, no data Available
When is Scandion Oncology A/S’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Scandion Oncology A/S’s earnings last quarter?
Currently, no data Available
Is Scandion Oncology A/S overvalued?
According to Wall Street analysts Scandion Oncology A/S’s price is currently Undervalued.
Does Scandion Oncology A/S pay dividends?
Scandion Oncology A/S does not currently pay dividends.
What is Scandion Oncology A/S’s EPS estimate?
Scandion Oncology A/S’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scandion Oncology A/S have?
Currently, no data Available
What happened to Scandion Oncology A/S’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Scandion Oncology A/S?
Currently, no hedge funds are holding shares in SE:SCOL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Scandion Oncology A/S
Scandion Oncology A/S (SCOL) is a biotechnology company specializing in developing innovative treatments to overcome drug resistance in cancer therapy. The company focuses on creating and advancing pharmaceutical solutions that enhance the effectiveness of existing cancer treatments. Scandion Oncology's core product portfolio includes proprietary drug candidates designed to counteract resistance mechanisms in cancer cells, thus improving patient outcomes in oncology sectors.